UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Dynamic evolution and trend prediction of multi-scale green innovation in China

Geography and sustainability, 2023-09, Vol.4 (3), p.222-231

2023

Volltextzugriff (PDF)

Identification of NVP-BKM120 as a Potent, Selective, Orally Bioavailable Class I PI3 Kinase Inhibitor for Treating Cancer

ACS medicinal chemistry letters, 2011-10, Vol.2 (10), p.774-779

2011

Volltextzugriff (PDF)

Hepatocyte Growth Factor Enhances Vascular Endothelial Growth Factor-Induced Angiogenesis in Vitro and in Vivo

The American journal of pathology, 2001-03, Vol.158 (3), p.1111-1120

2001

Volltextzugriff (PDF)

Enhancing sustainable development: Innovation ecosystem coopetition, environmental resource orchestration, and disruptive green innovation

Business strategy and the environment, 2023-05, Vol.32 (4), p.1388-1402

2023

Volltextzugriff (PDF)

CHIR-258 Is Efficacious in A Newly Developed Fibroblast Growth Factor Receptor 3–Expressing Orthotopic Multiple Myeloma Model in Mice

Clinical cancer research, 2006-08, Vol.12 (16), p.4908-4915

2006

Volltextzugriff (PDF)

The relationship between progesterone and Th-related cytokines in plasma during early pregnancy in cows

Frontiers of Agricultural Science and Engineering, 2016-06, Vol.3 (2), p.147-152

2016

Volltextzugriff (PDF)

Gene Expression Profiling in an in Vitro Model of Angiogenesis

The American journal of pathology, 2000-06, Vol.156 (6), p.1887-1900

2000

Volltextzugriff (PDF)

User participation, knowledge management capability and service innovation: e-commerce enterprises in the digital age

Asia Pacific journal of marketing and logistics, 2022-03, Vol.34 (4), p.629-646

2022

Volltextzugriff (PDF)

Synthesis and in Vitro and in Vivo Evaluation of Phosphoinositide-3-kinase Inhibitors

ACS medicinal chemistry letters, 2011-01, Vol.2 (1), p.34-38

2011

Volltextzugriff (PDF)

First-in-Human Study of PF-06647020 (Cofetuzumab Pelidotin), an Antibody-Drug Conjugate Targeting Protein Tyrosine Kinase 7, in Advanced Solid Tumors

Clinical cancer research, 2021-08, Vol.27 (16), p.4511-4520

2021

Volltextzugriff (PDF)

Abstract 4035: Protein tyrosine kinase 7 (PTK7) biomarker analysis in patients (pts) treated with PF-06647020, a PTK7 antibody-drug conjugate (ADC), in a phase I dose expansion study

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.4035-4035

2019

Volltextzugriff (PDF)

Characterization of the α1B-adrenergic Receptor Gene Promoter Region and Hypoxia Regulatory Elements in Vascular Smooth Muscle

Proceedings of the National Academy of Sciences - PNAS, 1997-08, Vol.94 (17), p.9487-9492

1997

Volltextzugriff (PDF)

Vascular endothelial cell growth factor-driven endothelial tube formation is mediated by vascular endothelial cell growth factor receptor-2, a kinase insert domain-containing receptor

Arteriosclerosis, thrombosis, and vascular biology, 2001-12, Vol.21 (12), p.1934-1940

2001

Volltextzugriff (PDF)

A phase 1b, open-label, single-arm study of cofetuzumab pelidotin (a PTK7-targeting antibody-drug conjugate) in patients with PTK7-expressing, recurrent non-small cell lung cancer (NSCLC)

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.TPS3142-TPS3142

2021

Volltextzugriff (PDF)

Clinical pharmacology assessment of PF-06647020 (PF-7020), an antibody-drug conjugate (ADC) targeting protein tyrosine kinase 7 (PTK7), in adult patients (pts) with advanced solid tumors

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.2574-2574

2018

Volltextzugriff (PDF)

Peroxisome proliferator-activated receptor gamma ligands are potent inhibitors of angiogenesis in vitro and in vivo

The Journal of biological chemistry, 1999-03, Vol.274 (13), p.9116-9121

1999

Volltextzugriff (PDF)

Platelet-Derived Growth Factor Inhibits α1D-Adrenergic Receptor Expression in Vascular Smooth Muscle Cells In Vitro and Ex Vivo

Molecular pharmacology, 1999-12, Vol.56 (6), p.1143-1151

1999

Volltextzugriff (PDF)

PF-06647020 (PF-7020), an antibody-drug conjugate (ADC) targeting protein tyrosine kinase 7 (PTK7), in patients (pts) with advanced solid tumors: Results of a phase I dose escalation and expansion study

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.5565-5565

2018

Volltextzugriff (PDF)

MSX2 mediates entry of human pluripotent stem cells into mesendoderm by simultaneously suppressing SOX2 and activating NODAL signaling

Cell research, 2015-12, Vol.25 (12), p.1314-1332

2015

Volltextzugriff (PDF)

Abstract 1220: A novel PTK7-targeted antibody-drug conjugate eliminates tumor-initiating cells and induces sustained tumor regressions

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.1220-1220

2016

Volltextzugriff (PDF)

SU6668 inhibits Flk‐1/KDR and PDGFRβ in vivo, resulting in rapid apoptosis of tumor vasculature and tumor regression in mice

The FASEB journal, 2002-05, Vol.16 (7), p.681-690

2002

Volltextzugriff (PDF)

Flow-resistance analysis of nano-confined fluids inspired from liquid nano-lubrication： A review

Chinese journal of chemical engineering, 2017-11, Vol.25 (11), p.1552-1562

2017

Volltextzugriff (PDF)

Single Cell Network Profiling (SCNP) Assay Reveals B Cell Receptor Signaling Heterogeneity In the Context of ZAP-70 Expression In Patients with Chronic Lymphocytic Leukemia (CLL)

Blood, 2010-11, Vol.116 (21), p.3586-3586

2010

Volltextzugriff (PDF)

Receptor-selective Variants of Human Vascular Endothelial Growth Factor

The Journal of biological chemistry, 2000-09, Vol.275 (38), p.29823-29828

2000

Volltextzugriff (PDF)

1 – 25 von 1.624

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.371)
Mit Volltextzugriff
(1.434)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.139)
Life Sciences & Biomedicine
(500)
Technology
(477)
Physical Sciences
(367)
Materials Science
(251)
Engineering
(237)
Chemistry
(200)
Materials Science, Multidisciplinary
(196)
Humans
(194)
Animals
(128)
Science & Technology - Other Topics
(128)
Physics
(126)
Female
(90)
Male
(87)
Chemistry, Multidisciplinary
(77)
Engineering, Electrical & Electronic
(77)
Nanoscience & Nanotechnology
(75)
Chemistry, Physical
(70)
Physics, Applied
(69)
Mice
(65)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Dynamic evolution and trend prediction of multi-scale green innovation in China

In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: Determination of a pharmacokinetic/pharmacodynamic relationship

Identification of NVP-BKM120 as a Potent, Selective, Orally Bioavailable Class I PI3 Kinase Inhibitor for Treating Cancer

Hepatocyte Growth Factor Enhances Vascular Endothelial Growth Factor-Induced Angiogenesis in Vitro and in Vivo

Enhancing sustainable development: Innovation ecosystem coopetition, environmental resource orchestration, and disruptive green innovation

CHIR-258 Is Efficacious in A Newly Developed Fibroblast Growth Factor Receptor 3–Expressing Orthotopic Multiple Myeloma Model in Mice

The relationship between progesterone and Th-related cytokines in plasma during early pregnancy in cows

Gene Expression Profiling in an in Vitro Model of Angiogenesis

User participation, knowledge management capability and service innovation: e-commerce enterprises in the digital age

Synthesis and in Vitro and in Vivo Evaluation of Phosphoinositide-3-kinase Inhibitors

First-in-Human Study of PF-06647020 (Cofetuzumab Pelidotin), an Antibody-Drug Conjugate Targeting Protein Tyrosine Kinase 7, in Advanced Solid Tumors

Abstract 4035: Protein tyrosine kinase 7 (PTK7) biomarker analysis in patients (pts) treated with PF-06647020, a PTK7 antibody-drug conjugate (ADC), in a phase I dose expansion study

Characterization of the α1B-adrenergic Receptor Gene Promoter Region and Hypoxia Regulatory Elements in Vascular Smooth Muscle

Vascular endothelial cell growth factor-driven endothelial tube formation is mediated by vascular endothelial cell growth factor receptor-2, a kinase insert domain-containing receptor

A phase 1b, open-label, single-arm study of cofetuzumab pelidotin (a PTK7-targeting antibody-drug conjugate) in patients with PTK7-expressing, recurrent non-small cell lung cancer (NSCLC)

Clinical pharmacology assessment of PF-06647020 (PF-7020), an antibody-drug conjugate (ADC) targeting protein tyrosine kinase 7 (PTK7), in adult patients (pts) with advanced solid tumors

Peroxisome proliferator-activated receptor gamma ligands are potent inhibitors of angiogenesis in vitro and in vivo

Platelet-Derived Growth Factor Inhibits α1D-Adrenergic Receptor Expression in Vascular Smooth Muscle Cells In Vitro and Ex Vivo

PF-06647020 (PF-7020), an antibody-drug conjugate (ADC) targeting protein tyrosine kinase 7 (PTK7), in patients (pts) with advanced solid tumors: Results of a phase I dose escalation and expansion study

MSX2 mediates entry of human pluripotent stem cells into mesendoderm by simultaneously suppressing SOX2 and activating NODAL signaling

Abstract 1220: A novel PTK7-targeted antibody-drug conjugate eliminates tumor-initiating cells and induces sustained tumor regressions

SU6668 inhibits Flk‐1/KDR and PDGFRβ in vivo, resulting in rapid apoptosis of tumor vasculature and tumor regression in mice

Flow-resistance analysis of nano-confined fluids inspired from liquid nano-lubrication： A review

Single Cell Network Profiling (SCNP) Assay Reveals B Cell Receptor Signaling Heterogeneity In the Context of ZAP-70 Expression In Patients with Chronic Lymphocytic Leukemia (CLL)

Receptor-selective Variants of Human Vascular Endothelial Growth Factor

Suchergebnisse filtern